{"id":"https://openalex.org/W3004821160","doi":"https://doi.org/10.1158/1535-7163.mct-19-0133","title":"Oxaliplatin\u2013DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy","display_name":"Oxaliplatin\u2013DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy","publication_year":2020,"publication_date":"2020-02-06","ids":{"openalex":"https://openalex.org/W3004821160","doi":"https://doi.org/10.1158/1535-7163.mct-19-0133","mag":"3004821160","pmid":"https://pubmed.ncbi.nlm.nih.gov/32029633","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7192311"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-19-0133","doi":"https://doi.org/10.1158/1535-7163.mct-19-0133","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-19-0133","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://escholarship.org/content/qt2202p5cs/qt2202p5cs.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049566673","display_name":"Maike Zimmermann","orcid":"https://orcid.org/0000-0001-9005-3795","observed_orcids":["https://orcid.org/0000-0001-9005-3795"]},"institutions":[{"id":"https://openalex.org/I4210102456","display_name":"Accelerated Medical Diagnostics (United States)","ror":"https://ror.org/00z0kkz74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102456"]},{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maike Zimmermann","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","2Accelerated Medical Diagnostics Incorporated, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]},{"raw_affiliation_string":"2Accelerated Medical Diagnostics Incorporated, Berkeley, California","institution_ids":["https://openalex.org/I4210102456"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100455312","display_name":"Tao Li","orcid":"https://orcid.org/0000-0002-5108-1774","observed_orcids":["https://orcid.org/0000-0002-5108-1774"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Li","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016991744","display_name":"Thomas John Semrad","orcid":"https://orcid.org/0000-0002-7810-5887","observed_orcids":["https://orcid.org/0000-0002-7810-5887"]},"institutions":[{"id":"https://openalex.org/I4210135768","display_name":"Tahoe Forest Hospital","ror":"https://ror.org/03m4w0286","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135768"]},{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Semrad","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","3Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California"],"raw_orcid":"https://orcid.org/0000-0002-7810-5887","affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]},{"raw_affiliation_string":"3Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California","institution_ids":["https://openalex.org/I4210135768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026305465","display_name":"Chun\u2010Yi Wu","orcid":"https://orcid.org/0000-0003-2642-0380","observed_orcids":["https://orcid.org/0000-0003-2642-0380"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chun-Yi Wu","raw_affiliation_strings":["4Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079729783","display_name":"Ai\u2010Ming Yu","orcid":"https://orcid.org/0000-0003-1441-4012","observed_orcids":["https://orcid.org/0000-0003-1441-4012"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aiming Yu","raw_affiliation_strings":["4Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013332373","display_name":"George D. Cimino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102456","display_name":"Accelerated Medical Diagnostics (United States)","ror":"https://ror.org/00z0kkz74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102456"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Cimino","raw_affiliation_strings":["2Accelerated Medical Diagnostics Incorporated, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Accelerated Medical Diagnostics Incorporated, Berkeley, California","institution_ids":["https://openalex.org/I4210102456"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003210173","display_name":"Michael A. Malfatti","orcid":"https://orcid.org/0000-0003-2431-9115","observed_orcids":["https://orcid.org/0000-0003-2431-9115"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Malfatti","raw_affiliation_strings":["5Lawrence Livermore National Laboratory, Livermore, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lawrence Livermore National Laboratory, Livermore, California","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089071405","display_name":"Kurt W. Haack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt Haack","raw_affiliation_strings":["5Lawrence Livermore National Laboratory, Livermore, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lawrence Livermore National Laboratory, Livermore, California","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008233399","display_name":"Kenneth W. Turteltaub","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth W. Turteltaub","raw_affiliation_strings":["5Lawrence Livermore National Laboratory, Livermore, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Lawrence Livermore National Laboratory, Livermore, California","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016546967","display_name":"Chong-xian Pan","orcid":"https://orcid.org/0000-0002-8588-3994","observed_orcids":["https://orcid.org/0000-0002-8588-3994"]},"institutions":[{"id":"https://openalex.org/I4210156491","display_name":"VA Northern California Health Care System","ror":"https://ror.org/05ts0bd12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210125474","https://openalex.org/I4210156491"]},{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chong-xian Pan","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","6Department of Urology, University of California Davis, Sacramento, California","7VA Northern California Health Care System, Mather, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]},{"raw_affiliation_string":"6Department of Urology, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I84218800"]},{"raw_affiliation_string":"7VA Northern California Health Care System, Mather, CA","institution_ids":["https://openalex.org/I4210156491"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080105357","display_name":"May Thet Cho","orcid":"https://orcid.org/0000-0002-7152-0017","observed_orcids":["https://orcid.org/0000-0002-7152-0017"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"May Cho","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100728167","display_name":"Edward Jae-Hoon Kim","orcid":"https://orcid.org/0000-0002-8660-7465","observed_orcids":["https://orcid.org/0000-0002-8660-7465"]},"institutions":[{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward J. Kim","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California"],"raw_orcid":"https://orcid.org/0000-0002-8660-7465","affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103140401","display_name":"Paul T. Henderson","orcid":"https://orcid.org/0000-0003-4238-0446","observed_orcids":["https://orcid.org/0000-0003-4238-0446"]},"institutions":[{"id":"https://openalex.org/I4210102456","display_name":"Accelerated Medical Diagnostics (United States)","ror":"https://ror.org/00z0kkz74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102456"]},{"id":"https://openalex.org/I4210160527","display_name":"University of California Davis Medical Center","ror":"https://ror.org/05t6gpm70","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160527","https://openalex.org/I4210160856"]},{"id":"https://openalex.org/I4390039352","display_name":"UC Davis Comprehensive Cancer Center","ror":"https://ror.org/02kcc1z29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210160856","https://openalex.org/I4390039352"]},{"id":"https://openalex.org/I84218800","display_name":"University of California, Davis","ror":"https://ror.org/05rrcem69","country_code":"US","type":"education","lineage":["https://openalex.org/I84218800"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul T. Henderson","raw_affiliation_strings":["1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","2Accelerated Medical Diagnostics Incorporated, Berkeley, California"],"raw_orcid":"https://orcid.org/0000-0003-4238-0446","affiliations":[{"raw_affiliation_string":"1Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California","institution_ids":["https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"]},{"raw_affiliation_string":"2Accelerated Medical Diagnostics Incorporated, Berkeley, California","institution_ids":["https://openalex.org/I4210102456"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5103140401"],"corresponding_institution_ids":["https://openalex.org/I4210102456","https://openalex.org/I4210160527","https://openalex.org/I4390039352","https://openalex.org/I84218800"],"apc_list":null,"apc_paid":null,"fwci":1.5062,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.83852913,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"4","first_page":"1070","last_page":"1079"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.042100001126527786,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.04010000079870224,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/dna-adducts","display_name":"DNA adducts","score":0.9290000200271606},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.8379999995231628},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9570000171661377},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9919999837875366},{"id":"https://openalex.org/keywords/oxaliplatin-neurotoxicity","display_name":"oxaliplatin neurotoxicity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9369999766349792},{"id":"https://openalex.org/keywords/accelerator-mass-spectrometry","display_name":"accelerator mass spectrometry","score":0.7770000100135803},{"id":"https://openalex.org/keywords/tumor-response-prediction","display_name":"tumor response prediction","score":0.5590000152587891},{"id":"https://openalex.org/keywords/plasma-pharmacokinetics","display_name":"plasma pharmacokinetics","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.9311932325363159},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.915317177772522},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.8050323724746704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5881951451301575},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.549096405506134},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48483097553253174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42305341362953186},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41989463567733765},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37596777081489563}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018736","descriptor_name":"DNA Adducts","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1535-7163.mct-19-0133","doi":"https://doi.org/10.1158/1535-7163.mct-19-0133","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-19-0133","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:32029633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32029633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt2202p5cs","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/2202p5cs","pdf_url":"https://escholarship.org/content/qt2202p5cs/qt2202p5cs.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, vol 19, iss 4","raw_type":"article"},{"id":"pmh:oai:osti.gov:1661031","doi":null,"is_oa":true,"landing_page_url":"https://www.osti.gov/biblio/1661031","pdf_url":"https://www.osti.gov/servlets/purl/1661031","source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"pmh:oai:escholarship.org:ark:/13030/qt3v16z9qs","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/3v16z9qs","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, vol 19, iss 4","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:escholarship.org:ark:/13030/qt2202p5cs","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/2202p5cs","pdf_url":"https://escholarship.org/content/qt2202p5cs/qt2202p5cs.pdf","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, vol 19, iss 4","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G112505928","display_name":null,"funder_award_id":"HHSN261201000133C","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1356433355","display_name":null,"funder_award_id":"DE\u2010AC5207NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G14554683","display_name":null,"funder_award_id":"DEAC5207NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G1679550197","display_name":null,"funder_award_id":"I01 BX003840","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G1716777315","display_name":null,"funder_award_id":"DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1728050654","display_name":"Feasibility of predicting AML response to induction chemotherapy","funder_award_id":"R43CA221473","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2145270357","display_name":null,"funder_award_id":"AC52\u201007NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G2684230466","display_name":null,"funder_award_id":"HHSN261201000133C","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G358449778","display_name":null,"funder_award_id":"HHSN261201200048C","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3669113783","display_name":null,"funder_award_id":"07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G4261132398","display_name":null,"funder_award_id":"08-LW-100","funder_id":"https://openalex.org/F4320337547","funder_display_name":"Laboratory Directed Research and Development"},{"id":"https://openalex.org/G4744444288","display_name":null,"funder_award_id":"DE- AC52-07NA27344","funder_id":"https://openalex.org/F4320337547","funder_display_name":"Laboratory Directed Research and Development"},{"id":"https://openalex.org/G5300104790","display_name":null,"funder_award_id":"HHSN261201200048C","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5630301777","display_name":null,"funder_award_id":"AC52-07NA27344","funder_id":"https://openalex.org/F4320337547","funder_display_name":"Laboratory Directed Research and Development"},{"id":"https://openalex.org/G632693473","display_name":null,"funder_award_id":"DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7591090225","display_name":"University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities","funder_award_id":"U54CA233306","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7938659809","display_name":null,"funder_award_id":"P30CA093373","funder_id":"https://openalex.org/F4320337900","funder_display_name":"Comprehensive Cancer Center, University of California, Davis"},{"id":"https://openalex.org/G8132368549","display_name":null,"funder_award_id":"I01 BX001784","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G8618207007","display_name":"Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)","funder_award_id":"P41RR013461","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G8920887855","display_name":"Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)","funder_award_id":"P41GM103483","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G895790057","display_name":null,"funder_award_id":"DE-AC52","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G9000859530","display_name":"UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program","funder_award_id":"K12CA138464","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000885888","display_name":"Cancer Center Support Grant P30","funder_award_id":"P30CA093373","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G991281326","display_name":null,"funder_award_id":"AC52-07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337547","display_name":"Laboratory Directed Research and Development","ror":"https://ror.org/01e41cf67"},{"id":"https://openalex.org/F4320337900","display_name":"Comprehensive Cancer Center, University of California, Davis","ror":"https://ror.org/02kcc1z29"},{"id":"https://openalex.org/F4320338286","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3004821160.pdf","grobid_xml":"https://content.openalex.org/works/W3004821160.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1973331584","https://openalex.org/W1986401321","https://openalex.org/W1998226812","https://openalex.org/W2014896394","https://openalex.org/W2019990270","https://openalex.org/W2034827986","https://openalex.org/W2053011422","https://openalex.org/W2058748287","https://openalex.org/W2062019219","https://openalex.org/W2094153418","https://openalex.org/W2097662572","https://openalex.org/W2114918609","https://openalex.org/W2138855878","https://openalex.org/W2146356730","https://openalex.org/W2146857332","https://openalex.org/W2147958275","https://openalex.org/W2171697262","https://openalex.org/W2279838407","https://openalex.org/W2523226757","https://openalex.org/W2557599064","https://openalex.org/W2566849612","https://openalex.org/W2582431780","https://openalex.org/W2606243128","https://openalex.org/W2608740459","https://openalex.org/W2617982897","https://openalex.org/W2760736965","https://openalex.org/W3118985080","https://openalex.org/W6682185206"],"related_works":["https://openalex.org/W2955415957","https://openalex.org/W3106182958","https://openalex.org/W3149662666","https://openalex.org/W2555034620","https://openalex.org/W4403764474","https://openalex.org/W4281746047","https://openalex.org/W2901210080","https://openalex.org/W2900049002","https://openalex.org/W2606135595","https://openalex.org/W2533110373"],"abstract_inverted_index":{"Abstract":[0],"FOLFOX":[1,56,83,176],"is":[2],"one":[3],"of":[4,29,80,117,124,194,199,232],"the":[5,21,27,148,200],"most":[6],"effective":[7],"treatments":[8],"for":[9,141],"advanced":[10],"colorectal":[11,90,100,153],"cancer.":[12],"However,":[13],"cumulative":[14],"oxaliplatin":[15,139],"neurotoxicity":[16],"often":[17],"results":[18],"in":[19,41,43,89,218],"halting":[20],"therapy.":[22,57,84],"Oxaliplatin":[23],"functions":[24],"predominantly":[25],"via":[26],"formation":[28,135],"toxic":[30],"covalent":[31],"drug\u2013DNA":[32],"adducts.":[33],"We":[34,58],"hypothesize":[35,60],"that":[36,61],"oxaliplatin\u2013DNA":[37,125],"adduct":[38,126,134,183,207],"levels":[39,184,208],"formed":[40],"vivo":[42],"peripheral":[44],"blood":[45],"mononuclear":[46],"cells":[47],"(PBMC)":[48],"are":[49,68,77],"proportional":[50,69,211],"to":[51,70,82,166,189],"tumor":[52,191],"shrinkage":[53],"caused":[54],"by":[55,64,73,147,157],"further":[59],"adducts":[62],"induced":[63,72],"subtherapeutic":[65],"\u201cdiagnostic":[66],"microdoses\u201d":[67],"those":[71],"therapeutic":[74],"doses":[75],"and":[76,94,214,222],"also":[78],"predictive":[79],"response":[81],"These":[85],"hypotheses":[86],"were":[87,104,209],"tested":[88],"cancer":[91,101,154],"cell":[92,102,143,219],"lines":[93,103],"a":[95,160,171,179],"pilot":[96],"clinical":[97],"study.":[98],"Four":[99],"cultured":[105],"with":[106,128,138],"therapeutically":[107,215],"relevant":[108,216],"(100":[109],"\u03bcmol/L)":[110,115],"or":[111],"diagnostic":[112,161,233],"microdose":[113,162,213],"(1":[114],"concentrations":[116,217],"[14C]oxaliplatin.":[118],"The":[119],"C-14":[120],"label":[121],"enabled":[122],"quantification":[123],"level":[127],"accelerator":[129],"mass":[130],"spectrometry":[131],"(AMS).":[132],"Oxaliplatin\u2013DNA":[133,182,206],"was":[136,226],"correlated":[137,187],"cytotoxicity":[140],"each":[142],"line":[144],"as":[145,168,170,225],"measured":[146],"MTT":[149],"viability":[150],"assay.":[151],"Six":[152],"patients":[155,202],"received":[156],"intravenous":[158],"route":[159],"containing":[163],"[14C]oxaliplatin":[164,173],"prior":[165],"treatment,":[167],"well":[169],"second":[172],"dose":[174],"during":[175],"chemotherapy,":[177],"termed":[178],"\u201ctherapeutic":[180],"dose.\u201d":[181],"from":[185],"PBMC":[186],"significantly":[188],"mean":[190],"volume":[192],"change":[193],"evaluable":[195],"target":[196],"lesions":[197],"(5":[198],"6":[201],"had":[203],"measurable":[204],"disease).":[205],"linearly":[210],"between":[212],"culture":[220],"experiments":[221],"patient":[223],"samples,":[224],"plasma":[227],"pharmacokinetics,":[228],"indicating":[229],"potential":[230],"utility":[231],"microdosing.":[234]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-02-14T00:00:00"}